Smoldering MM (SMM) is a precursor state of MM, characterized by M‐protein ≥30 g/l or bone marrow plasma cell percentage of 10–60% without end‐organ damage or presence of biomarkers of malignancy 121, 122. This evidence concerns the gene MYOM2 and Miyoshi myopathy.